Submission Details
| 510(k) Number | K252569 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 14, 2025 |
| Decision Date | October 22, 2025 |
| Days to Decision | 69 days |
| Submission Type | Special |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K252569 is an FDA 510(k) clearance for the Carrier XL Delivery Catheter, a Catheter, Percutaneous, Neurovasculature (Class II — Special Controls, product code QJP), submitted by Balt USA, LLC (Irvine, US). The FDA issued a Cleared decision on October 22, 2025, 69 days after receiving the submission on August 14, 2025. This device falls under the Neurology review panel. Regulated under 21 CFR 870.1250.
| 510(k) Number | K252569 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 14, 2025 |
| Decision Date | October 22, 2025 |
| Days to Decision | 69 days |
| Submission Type | Special |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | QJP — Catheter, Percutaneous, Neurovasculature |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.1250 |
| Definition | To Provide Vascular Access To The Neurovasculature For Interventional Or Diagnostic Procedures |